ALT

2.93

1.38% 0.03

Handel nachbörslich: 2.96 0.03 +1.02%

Altimmune Inc (ALT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$2.90

Offen:

$2.9

24-Stunden-Volumen:

2.13M

Relative Volume:

0.55

Marktkapitalisierung:

$569.81M

Einnahmen:

$41,000

Nettoeinkommen (Verlust:

$-88.09M

KGV:

-2.8856

EPS:

-1.0154

Netto-Cashflow:

$-67.55M

1W Leistung:

+7.30%

1M Leistung:

+3.16%

6M Leistung:

-43.13%

1J Leistung:

-48.51%

1-Tages-Spanne:

$2.894

$3.00

1-Wochen-Bereich:

$2.73

$3.00

52-Wochen-Spanne:

$2.56

$7.73

Altimmune Inc Stock (ALT) Company Profile

Firmenname

Altimmune Inc

Sektor

Healthcare (1113)

Branche

Biotechnology (618)

Telefon

(240) 654-1450

Adresse

910 CLOPPER ROAD, GAITHERSBURG, MD

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-05-13

Neueste SEC-Einreichungen

ALT's Discussions on Twitter

Compare ALT vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALT Altimmune Inc	2.93	563.98M	41,000	-88.09M	-67.55M	-1.0154
VRTX Vertex Pharmaceuticals Inc	435.92	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.42	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.61	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Altimmune Inc Stock (ALT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-24	Hochstufung	Goldman	Sell → Neutral
2026-03-18	Eingeleitet	Truist	Buy
2026-01-28	Eingeleitet	Barclays	Overweight
2025-07-10	Fortgesetzt	Goldman	Sell
2025-02-28	Eingeleitet	William Blair	Mkt Perform
2025-01-08	Eingeleitet	Stifel	Buy
2024-11-12	Eingeleitet	UBS	Buy
2024-04-29	Herabstufung	Guggenheim	Buy → Neutral
2024-01-24	Eingeleitet	Goldman	Neutral
2023-03-22	Herabstufung	Goldman	Buy → Neutral
2022-12-01	Eingeleitet	Goldman	Buy
2021-12-29	Fortgesetzt	Jefferies	Buy
2021-06-02	Eingeleitet	H.C. Wainwright	Buy
2021-02-11	Eingeleitet	Guggenheim	Buy
2020-12-14	Eingeleitet	Jefferies	Buy
2020-11-12	Bestätigt	B. Riley Securities	Buy
2020-09-25	Eingeleitet	B. Riley FBR	Buy
2020-08-14	Eingeleitet	Evercore ISI	Outperform
2020-07-31	Eingeleitet	Piper Sandler	Overweight
2020-07-28	Eingeleitet	JMP Securities	Mkt Outperform
2020-02-24	Fortgesetzt	ROTH Capital	Buy
2019-07-19	Eingeleitet	ROTH Capital	Buy
2017-10-09	Eingeleitet	Piper Jaffray	Overweight

Alle ansehen

Altimmune Inc Aktie (ALT) Neueste Nachrichten

07:36 AM

H.C. Wainwright cuts Altimmune stock price target on dilution - Investing.com India

May 19, 2026

H.C. Wainwright cuts Altimmune stock price target on dilution By Investing.com - Investing.com South Africa

May 19, 2026

H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20 - Moomoo

May 19, 2026

Several Insiders Invested In Altimmune Flagging Positive News - simplywall.st

May 19, 2026

May 18, 2026

ALT Maintained by HC Wainwright & Co. -- Price Target Lowered to $20 - GuruFocus

May 18, 2026

H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Cuts Target Price to $20 - Moomoo

May 18, 2026

Altimmune Price Target Cut to $20.00/Share From $25.00 by HC Wainwright & Co. - Moomoo

May 18, 2026

Altimmune Inc Price USD, ALT Price Live Charts, Market Cap & News - Bitget

May 18, 2026

May 16, 2026

ALT: Altimmune Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

May 16, 2026

May 15, 2026